Allkem’s strong 2022-23 results pave the way for merger with Livent
Australian-Argentinian lithium conglomerate Allkem (ASX:AKE) has positioned itself favorably for an impending merger with its US-based counterpart, Livent, following the disclosure of its robust 2022-23 financial performance. Allkem reported a full-year profit of $524.6 million USD ($817 million AUD) ahead of a crucial shareholder vote on its upcoming union with Livent, slated for later this […]
Allkem’s strong 2022-23 results pave the way for merger with Livent Read More »